FDA Grants Accelerated Approval to Braftovi for Some Patients With Metastatic Colorectal Cancer

The FDA granted accelerated approval to encorafenib (Braftovi, Array BioPharma, a subsidiary of Pfizer) with ...

JANUARY 14, 2025